Skillman, NJ (August 15, 2012) – The Johnson & Johnson Family of Consumer Companies today announced the launch of www.SafetyandCareCommitment.com an initiative to help consumers better understand all the measures we take to make our beauty and baby care products as safe as can be.
“There’s a public discussion underway about the ingredients in beauty care products, and we think it’s important to be part of that,” said Susan Nettesheim, Vice President of Product Stewardship & Toxicology for Johnson & Johnson Consumer Companies, Inc. “Consumers today expect more information and greater transparency than ever before and we’re always listening to the people who use our products. On this site, we’ll do our best to explain how we make the choices we make, and to show how our plans incorporate consumers’ feedback. We want all consumers to see for themselves how and why every one of our products can be used with peace of mind.”
SafetyandCareCommitment.com includes information about how ingredients are selected and evaluated, and provides details on our gold standard safety assurance process. The site will evolve and be updated to incorporate consumer feedback, the latest science, new regulations and new information about our policies. The site contains information about our approach to research, the extra care we put into the development of products for babies and toddlers, and our commitment to sustainability.
Visitors to the site will also find information about some of the topics they’ve been reading about in the news, like the role of preservatives and fragrances. The site shares the Johnson & Johnson Family of Consumer Companies’ future plans for a number of ingredients that have been in the public eye. “We’ve decided to phase-out or reduce certain ingredients that are safe by scientific standards and considered safe by key regulators around the world including the EU, the U.S. and China. We’re doing this because we’re listening to the people who rely on our products, and if they have concerns, we’re committed to addressing them, as long as we can do so safely and effectively. We want to be sure people have peace of mind bringing our products into their homes and caring for themselves and their families. Nothing is more important to us,” said Nettesheim.
At the site, visitors will hear and see scientists discuss the five-level safety process that we use, and the principles that guide our approach to safety for every one of our brands worldwide. Brands like JOHNSON’S® Baby, NEUTROGENA®, AVEENO®, RoC® and CLEAN & CLEAR® are part of people’s daily routines, and important to how they care for themselves and their families. This website is a place they can go to learn more about what goes into making sure the products they use every day are safe and effective.
“People already know that our products and ingredients meet or exceed government regulatory standards. They want to know more,” said Nettesheim. “This site provides moms, families and all consumers a way to hear directly from us about the art and science of ingredient selection and product formulation.” She adds, “We want to share our policies and plans in a forum that is designed to help consumers better understand what we do to ensure that the products they choose are as safe as can be.“
About the Johnson & Johnson Family of Consumer Companies
The Johnson & Johnson Family of Consumer Companies includes, among other divisions, Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc., which markets the JOHNSON’S® baby, AVEENO®, RoC®, and CLEAN & CLEAR® brands, and Neutrogena Corporation, which markets the NEUTROGENA® brand.
Caring for the world, one person at a time…inspires and unites the people of the Johnson & Johnson Family of Consumer Companies. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. The Johnson & Johnson Family of Consumer Companies is part of the more than 250 operating companies of Johnson & Johnson (NYSE: JNJ), working with partners in health care to touch the lives of over a billion people every day, throughout the world.
(This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to, general industry conditions and competition; economic factors, such as interest rate and currency exchange rate fluctuations; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; challenges to patents; significant adverse litigation or government action; impact of business combinations; financial distress and bankruptcies experienced by significant customers and suppliers; changes to governmental laws and regulations and domestic and foreign health care reforms; trends toward health care cost containment; increased scrutiny of the health care industry by government agencies; changes in behavior and spending patterns of purchasers of health care products and services; financial instability of international economies and sovereign risk; disruptions due to natural disasters; manufacturing difficulties or delays; and product efficacy or safety concerns resulting in product recalls or regulatory action. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended January 1, 2012. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.investor.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statements as a result of new information or future events or developments.)
MEDIA CONTACT:
Sam Lucas
Slucas12@its.jnj.com
732-524-3886 (office)
718-715-3359 (mobile)